Literature DB >> 21144985

Appropriateness is critical.

Marta Ulldemolins1, Xavier Nuvials, Mercedes Palomar, Joan R Masclans, Jordi Rello.   

Abstract

Inappropriate empirical antibiotic therapy for severe infections in the intensive care unit is a modifiable prognostic factor that has a great effect on patient outcome and health care resources. Inappropriate treatment is usually associated with microorganisms resistant to the common antibiotics, which must be empirically targeted when risk factors are present. Previous antibiotic exposure, prolonged length of hospital stay, admission category, local susceptibilities, colonization pressure, and the presence of invasive devices increase the likelihood of infection by resistant pathogens. Consideration of issues beyond in vitro susceptibility, such as antibiotic physicochemistry, tissue penetration, and pharmacokinetic/pharmacodynamic-driven dosing, is mandatory for the optimization of antibiotic use.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21144985     DOI: 10.1016/j.ccc.2010.09.007

Source DB:  PubMed          Journal:  Crit Care Clin        ISSN: 0749-0704            Impact factor:   3.598


  7 in total

1.  Expert clinical pharmacological advice may make an antimicrobial TDM program for emerging candidates more clinically useful in tailoring therapy of critically ill patients.

Authors:  Milo Gatti; Pier Giorgio Cojutti; Michele Bartoletti; Tommaso Tonetti; Amedeo Bianchini; Stefania Ramirez; Giacinto Pizzilli; Simone Ambretti; Maddalena Giannella; Rita Mancini; Antonio Siniscalchi; Pierluigi Viale; Federico Pea
Journal:  Crit Care       Date:  2022-06-14       Impact factor: 19.334

2.  Guidelines for diagnosis and management of community- and hospital-acquired pneumonia in adults: Joint ICS/NCCP(I) recommendations.

Authors:  Dheeraj Gupta; Ritesh Agarwal; Ashutosh Nath Aggarwal; Navneet Singh; Narayan Mishra; G C Khilnani; J K Samaria; S N Gaur; S K Jindal
Journal:  Lung India       Date:  2012-07

3.  Antimicrobial therapeutic determinants of outcomes from septic shock among patients with cirrhosis.

Authors:  Yaseen M Arabi; Saqib I Dara; Ziad Memish; Abdulmajeed Al Abdulkareem; Hani M Tamim; Nehad Al-Shirawi; Joseph E Parrillo; Peter Dodek; Stephen Lapinsky; Daniel Feinstein; Gordon Wood; Sandra Dial; Sergio Zanotti; Anand Kumar
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

4.  Optimal aminoglycoside therapy following the sepsis: how much is too much?

Authors:  Laleh Mahmoudi; Ramin Niknam; Sarah Mousavi; Arezoo Ahmadi; Hooshyar Honarmand; Shadi Ziaie; Mojtaba Mojtahedzadeh
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

5.  How to measure the impacts of antibiotic resistance and antibiotic development on empiric therapy: new composite indices.

Authors:  Josie S Hughes; Amy Hurford; Rita L Finley; David M Patrick; Jianhong Wu; Andrew M Morris
Journal:  BMJ Open       Date:  2016-12-16       Impact factor: 2.692

6.  Antibiotic prescriptions in critically-ill patients: a latin american experience.

Authors:  D Curcio
Journal:  Ann Med Health Sci Res       Date:  2013-04

7.  Improved empirical antibiotic treatment of sepsis after an educational intervention: the ABISS-Edusepsis study.

Authors:  Ricard Ferrer; María Luisa Martínez; Gemma Gomà; David Suárez; Luis Álvarez-Rocha; María Victoria de la Torre; Gumersindo González; Rafael Zaragoza; Marcio Borges; Jesús Blanco; Eduardo Palencia Herrejón; Antonio Artigas
Journal:  Crit Care       Date:  2018-06-22       Impact factor: 9.097

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.